{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:57Z","timestamp":1787729457507,"version":"build-2784847793"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Laboratory testing for the identification of heritable thrombophilia in high\u2010risk patient groups have become common practice; however, indiscriminate testing of all patients is unjustified. The objective of this study was to evaluate the cost\u2010effectiveness of universal and selective history\u2010based thrombophilia screening relative to no screening, from the perspective of the UK National Health Service, in women prior to prescribing combined oral contraceptives and hormone replacement therapy, women during pregnancy and patients prior to major orthopaedic surgery. A decision analysis model was developed, and data from meta\u2010analysis, the literature and two Delphi studies were incorporated in the model. Incremental cost\u2010effectiveness ratios (ICERs) for screening compared with no screening was calculated for each patient group. Of all the patient groups evaluated, universal screening of women prior to prescribing hormone replacement therapy was the most cost\u2010effective (ICER \u00a36824). In contrast, universal screening of women prior to prescribing combined oral contraceptives was the least cost\u2010effective strategy (ICER \u00a3202\u2003402). Selective thrombophilia screening based on previous personal and\/or family history of venous thromboembolism was more cost\u2010effective than universal screening in all the patient groups evaluated.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05715.x","type":"journal-article","created":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T07:47:37Z","timestamp":1125560857000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Screening for thrombophilia in high\u2010risk situations: a meta\u2010analysis and cost\u2010effectiveness analysis"],"prefix":"10.1111","volume":"131","author":[{"given":"Olivia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Twaddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Brenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Greaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langhorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,9,20]]},"reference":[{"key":"e_1_2_5_2_1","volume-title":"Spontaneous Abortion: Diagnosis and Treatment","author":"Alberman E.","year":"1992"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.4.332"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.01.017"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03203.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08740-8"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00318-0"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07113-9"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4733.2000.36005.x"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/02729890222063008"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02185.x"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/beog.2001.0202"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341203"},{"key":"e_1_2_5_15_1","volume-title":"Scottish Health Statistics","author":"Information and Statistics Division","year":"2001"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7001.376"},{"key":"e_1_2_5_17_1","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood.V85.10.2756.bloodjournal85102756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)","volume":"85","author":"Koster T.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614592"},{"key":"e_1_2_5_19_1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0037-1616085","article-title":"Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t\u2010PA, PAI and C\u2010reactive protein \u2013 a cross\u2010sectional population survey","volume":"86","author":"Lowe G.D.","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00168.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.7.365"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00167.x"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199801000-00009"},{"key":"e_1_2_5_24_1","volume-title":"Scottish Health Service Costs","author":"National Health Service in Scotland","year":"2003"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30289-6"},{"key":"e_1_2_5_26_1","author":"Nelson\u2010Piercy C.","year":"2004","journal-title":"Thromboprophylaxis During pregnancy, Labour and After Vaginal Delivery"},{"key":"e_1_2_5_27_1","first-page":"293","article-title":"Screening for activated protein C resistance before oral contraceptive treatment: a pilot study","volume":"59","author":"Palareti G.","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7083.796"},{"key":"e_1_2_5_29_1","article-title":"Accuracy of laboratory diagnosis of familial thrombophilia, 2001\u20132002: UK NEQAS","volume":"1","author":"Preston F.E.","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200412000-00003"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00264.x"},{"key":"e_1_2_5_32_1","first-page":"1410","article-title":"Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool","volume":"88","author":"Samama M.M.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_5_33_1","first-page":"883","article-title":"Recurrent stillbirth. Significance and characteristics","volume":"38","author":"Samueloff A.","year":"1993","journal-title":"Journal of Reproductive Medicine"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14066-4"},{"key":"e_1_2_5_35_1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1055\/s-0038-1665437","article-title":"Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives","volume":"78","author":"Schambeck C.M.","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_5_36_1","volume-title":"Prophylaxis of Venous Thromboembolism (SIGN Guideline 62)","author":"SIGN","year":"2002"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.20.2260"},{"key":"e_1_2_5_38_1","first-page":"1","article-title":"HRT: an update on the risk of breast cancer and long\u2010term safety","volume":"29","author":"UK Committee of Safety of Medicines and Medicines and Healthcare products Regulatory Agency","year":"2003","journal-title":"Current Problems in Pharmacovigilance"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.8.573"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02981.x"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01264.x"},{"key":"e_1_2_5_42_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review","volume":"94","author":"Wu O.","year":"2005","journal-title":"Thrombosis and Haemostasis"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05715.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05715.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:40:03Z","timestamp":1697380803000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05715.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,20]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05715.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05715.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,20]]},"assertion":[{"value":"2005-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}